Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common methodological flaws in economic evaluations.

Michael Drummond1, Mark Sculpher

  • 1Centre for Health Economics, University of York, York, United Kingdom. chedir@york.ac.uk

Medical Care
|August 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep-Learning Solution Providing Molecular Marker Subtyping of Breast Cancer Whole Slide Images: Protocol for a UK Clinical Service Evaluation Study.

JMIR research protocols·2026
Same author

Protocol for the health economic evaluation of nature-based social prescribing against loneliness alongside the RECETAS trials.

BMC public health·2026
Same author

The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trial.

Contemporary clinical trials·2026
Same author

What is the Value of Developing an HTA Process?

PharmacoEconomics·2026
Same author

Modelling the cost-effectiveness of interventions to treat or prevent neuropathic ulcers arising from leprosy: application to L-PRF.

Cost effectiveness and resource allocation : C/E·2026
Same author

Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication.

Applied health economics and health policy·2026
Same journal

Hepatitis C Virus Cascade of Care in Florida Emergency Departments.

Medical care·2026
Same journal

Association of Neighborhood Socioeconomic Disadvantage and Uptake of Diabetes Prevention Interventions.

Medical care·2026
Same journal

Machine Learning for Evaluating the Heterogeneous Effects of Intensive In-Hospital Rehabilitation During the Postacute Phase After Hip Fracture Surgery on Activities of Daily Living.

Medical care·2026
Same journal

Hospital-Physician Integration and Differences in the Use of Orthopedic Care Across Race and Ethnicity.

Medical care·2026
Same journal

Temporal Misalignment and Selection Bias in "Burn Pit Smoke Exposure and Sleep Apnea in US Veterans.

Medical care·2026
Same journal

The Impact of an Oncology Hospital at Home Program on Health Care Costs.

Medical care·2026
See all related articles

This study identifies common methodological flaws in economic evaluations used for health technology reimbursement decisions. Addressing these issues is crucial for reliable healthcare decision-making and resource allocation.

Area of Science:

  • Health Economics
  • Health Technology Assessment
  • Decision Sciences

Background:

  • Economic evaluations are vital for health technology reimbursement decisions by government agencies and managed care groups.
  • Reviews indicate significant methodological deficiencies and non-adherence to guidelines in existing economic evaluations.
  • These flaws can impact the reliability of evidence used for healthcare policy.

Purpose of the Study:

  • To outline common methodological flaws in economic evaluations relevant to health technology reimbursement.
  • To provide guidance for healthcare decision-makers on identifying and avoiding these deficiencies.
  • To improve the quality and utility of economic evaluations in healthcare.

Main Methods:

  • Review and synthesis of common methodological flaws identified in economic evaluation literature.

Related Experiment Videos

  • Focus on issues critical for reimbursement and guidance-for-use decisions.
  • Inclusion of examples from published studies to illustrate flaws.

    • Main Results:

    • Identified eleven key methodological flaws, including omission of costs/benefits, inappropriate comparators, indirect comparison issues, and inadequate effectiveness data.
    • Highlighted problems with extrapolation, reliance on assumptions, uncertainty characterization, result aggregation, and reporting of average ratios.
    • Noted issues with generalizability and selective reporting of findings.

    Conclusions:

    • Awareness and detection of these methodological flaws are essential for users of economic evaluations.
    • Addressing these deficiencies will enhance the validity and applicability of economic evaluations for health technology assessment.
    • Improved methodological rigor in economic evaluations supports evidence-based healthcare reimbursement and policy.